Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29

Surgical Endoscopy

Volumn 23, Issue 6, 2009, Pages 1313-1320

  DePaula, A L ^a,b   Macedo, A L V ^b,c   Mota, B R ^b   Schraibman, V ^b,c  

^a Hospital de Especialidades ^*  (Brazil)

^b HOSPITAL DE ESPECIALIDADES   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Ileal interposition; Metabolic syndrome; Neuroendocrine brake; Obesity; Sleeve gastrectomy; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; DUODENUM; DYSLIPIDEMIA; FEMALE; GASTRECTOMY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ILEUM; INSULIN RESISTANCE; KIDNEY DISEASE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETINOPATHY; ANASTOMOSIS; BLOOD; COMPARATIVE STUDY; FOLLOW UP; LAPAROSCOPY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME;

ADULT; ANASTOMOSIS, SURGICAL; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DUODENUM; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; ILEUM; LAPAROSCOPY; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 68849124506     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-008-0156-x     Document Type: Article

References (20)

1. Ranganath LR (2008) The entero-insular axis: implications for human metabolism. Clin Chem Lab Med 46:43-56
2. Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA (1998) A new paradigm for type 2 diabetes mellitus? Could it be a disease of the foregut? Ann Surg 227:637-644
3. Greenway SE, Greenway FL, Klein S (2002) Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 137:1109-1117
4. Patriti A, Facchiano E, Sanna A, Gulla N, Donini A (2004) The enteroinsular axis and the recovery from type II diabetes after bariatric surgery. Obesity 14:840-848
5. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagnet M, Marescaux J (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741-749
6. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ (2005) Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 288:E447-E453
7. Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A (2005) Early improvement of glucose tolerance after ileal transposition in a nonobese type 2 diabetes rat model. Obes Surg 15:1258-1264
8. DePaula AL, Macedo ALV, Rassi N, Machado CA, Schraibman V, Silva LQ, Halpern H (2008) Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 22:706-16
9. American Diabetes Association (2006) Standards of medical care in diabetes: position statement. Diabetes Care 29(Suppl 1):S4-S42
10. Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G, Ren C (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and bilipancreatic diversion. J Am Coll Surg 205:631-635
11. Gumbs AA, Modlin IM, Ballantyne GH (2005) Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 15:462-473
12. Flatt PR (2007) Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs? Diab Vasc Dis Res 4:151-153
13. Dolan K, Hatzifotis M, Newbury L (2004) A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesitiy. Obes Surg 14:165-169
14. Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocrine Rev 19:491-503
15. Gault VA, Irwin N, Green BD, Mccluskey JT, Greer B, Bailey CJ, Harriott P, O'Harte, FPM, Flatt PR (2005) Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro 3) GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesityrelated diabetes. Diabetes 54:2436-2446
16. Zhou H, Yamada Y, Tsukiyama K, Miyawaki K, Hosokawa M, Nagashima K, Toyoda K, Naitoh R, Mizunoya W, Fushiki T, Kadowaki T, Seino Y (2005) Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action. Biochem Biophys Res Commun 335:937-942
17. Theodorakis MJ, Carlson O, Muller DC, Egan JM (2004) Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care 27:1692-1698
18. Cryer PE (2002) Hypoglycaemia: the limiting factor in the glycaemic management in type 1 and type 2 diabetes. Diabetologia 45:937-948
19. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
20. DePaula AL, Macedo ALV, Rassi N, Vencio S, Machado CA, Mota BR, Silva LQ, Halpern A, Schraibman V (2008) Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc [Epub ahead of print]